Fig. 1
Distribution of EGFR, HER2, c-MYC, and MET genetic alterations according to (a) amplification data, (b) GCN gain results and (c) ASCO/CAP criterion
Fig. 1 | Journal of Translational Medicine
Distribution of EGFR, HER2, c-MYC, and MET genetic alterations according to (a) amplification data, (b) GCN gain results and (c) ASCO/CAP criterion